Tower Research Capital (TRC)’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33.9K | Sell |
15,465
-5,424
| -26% | -$11.9K | ﹤0.01% | 3310 |
|
2025
Q1 | $22.6K | Buy |
20,889
+15,584
| +294% | +$16.8K | ﹤0.01% | 2847 |
|
2024
Q4 | $5.52K | Buy |
5,305
+1,596
| +43% | +$1.66K | ﹤0.01% | 4275 |
|
2024
Q3 | $4.64K | Sell |
3,709
-9,922
| -73% | -$12.4K | ﹤0.01% | 4464 |
|
2024
Q2 | $16.2K | Sell |
13,631
-7,094
| -34% | -$8.44K | ﹤0.01% | 3874 |
|
2024
Q1 | $20.9K | Buy |
20,725
+15,371
| +287% | +$15.5K | ﹤0.01% | 2958 |
|
2023
Q4 | $5.68K | Sell |
5,354
-3,660
| -41% | -$3.88K | ﹤0.01% | 4816 |
|
2023
Q3 | $14.8K | Buy |
9,014
+1,971
| +28% | +$3.23K | ﹤0.01% | 3657 |
|
2023
Q2 | $11.1K | Sell |
7,043
-1,533
| -18% | -$2.41K | ﹤0.01% | 3994 |
|
2023
Q1 | $12K | Buy |
8,576
+7,370
| +611% | +$10.3K | ﹤0.01% | 4121 |
|
2022
Q4 | $3K | Sell |
1,206
-1,475
| -55% | -$3.67K | ﹤0.01% | 5229 |
|
2022
Q3 | $5K | Sell |
2,681
-1,074
| -29% | -$2K | ﹤0.01% | 5170 |
|
2022
Q2 | $8K | Buy |
3,755
+3,291
| +709% | +$7.01K | ﹤0.01% | 4706 |
|
2022
Q1 | $3K | Sell |
464
-430
| -48% | -$2.78K | ﹤0.01% | 5413 |
|
2021
Q4 | $5K | Sell |
894
-2,196
| -71% | -$12.3K | ﹤0.01% | 5189 |
|
2021
Q3 | $28K | Buy |
3,090
+2,715
| +724% | +$24.6K | ﹤0.01% | 3433 |
|
2021
Q2 | $4K | Sell |
375
-979
| -72% | -$10.4K | ﹤0.01% | 4834 |
|
2021
Q1 | $12K | Buy |
1,354
+86
| +7% | +$762 | ﹤0.01% | 4275 |
|
2020
Q4 | $7K | Buy |
1,268
+808
| +176% | +$4.46K | ﹤0.01% | 4504 |
|
2020
Q3 | $1K | Sell |
460
-1,272
| -73% | -$2.77K | ﹤0.01% | 4732 |
|
2020
Q2 | $5K | Buy |
+1,732
| New | +$5K | ﹤0.01% | 4294 |
|
2017
Q3 | – | Sell |
-23
| Closed | -$20K | – | 4189 |
|
2017
Q2 | $20K | Sell |
23
-14
| -38% | -$12.2K | ﹤0.01% | 1223 |
|
2017
Q1 | $34K | Buy |
37
+30
| +429% | +$27.6K | ﹤0.01% | 950 |
|
2016
Q4 | $20K | Buy |
+7
| New | +$20K | ﹤0.01% | 2150 |
|